HSV Transmitted Through Breastfeeding Can Kill Babies; CBCD Reviews the Medical Evidence
Herpes transmission from mother to baby through lesions on the breast can be fatal. (1)
Rochester, NY -- (SBWire) -- 09/10/2015 --"Infected with the herpes simplex virus (HSV-1 or HSV-2)? The CBCD recommends taking Gene-Eden-VIR or Novirin." – Greg Bennett, CBCD
Although most cases of neonatal herpes infection occur due to transmission of genital herpes (HSV-2) to a baby during the birthing process, HSV-1 can also "lead to fatal neonatal disease." (1) In fact, "HSV-1 transmission by genital or extragenital means may result in greater mortality rates." (1) Another study showed that in up to 10% of cases, "the infection is transmitted postnatally (after birth), most often due to direct contact with an oral HSV infection." (2)
"HSV infection of the nipple or areola can be exquisitely painful and tends to present as miniature vesicles (sores) on an erythematous (skin) base. Open vesicles carry the virus, and the virus can then be transmitted to the breastfeeding infant. It is critical to rule out HSV in infants less than 3 months of age because they can develop a life threatening infection involving the central nervous system." (3)
A baby that becomes infected with herpes must be treated with an I.V. that administers the antiviral drug, acyclovir. Thus, it is very important to know if a nipple is infected. As study authors wrote, "It is important to remember that any breast lesion is not a benign cold sore and may be an herpes infection. This presentation is little known and probably underestimated. In cases of questionable breast lesions, a sample should be urgently tested for HSV. If positive, breastfeeding should be discontinued until the resolution of local signs and negativity of samples (2)."
The Center for the Biology of Chronic Disease (CBCD) recommends helping the immune system to target the herpes virus while it is latent, and before a woman becomes pregnant, or after she delivers the baby by taking Gene-Eden-VIR or Novirin.
Click to learn more about herpes symptoms.
The formula of Novirin and Gene-Eden-VIR was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Gene-Eden-VIR and Novirin formula is effective against the herpes virus (HSV-1 and HSV-2), and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, "individuals infected with HCV … reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR." (4) The study authors also wrote that "we observed a statistically significant decrease in the severity, duration, and frequency of symptoms." (4)
Both products can be ordered online on the Gene-Eden-VIR and Novirin websites, here:
http://www.gene-eden-vir.com and http://www.novirin.com
Novirin and Gene-Eden-VIR are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.
Note: Novirin has the same formula as Gene-Eden-VIR. However, it contains higher quality and more expensive ingredients.
In the study mentioned above, doctors described a case wherein a baby was infected with the herpes virus (HSV-1) through sores on the breast. Dr. Field wrote that "The lesions were seen by nurses as well as the lactation consultant and obstetrician in the hospital after delivery of the affected baby but not recognized as possibly being caused by herpes. The baby died 9 days after birth with hepatic failure." Dr. Field is from the Department of Pediatrics, Huntsville Hospital, USA.
Are there other antiviral treatments against the herpes virus?
"Two types of antiviral treatments against HSV are available: topical and oral. The treatments include penciclovir, acyclovir, famciclovir, and valaciclovir. However, their effectiveness is limited. For instance, a meta-analysis of five placebo-controlled and two dose comparison studies evaluated the effect of aciclovir, famciclovir or valaciclovir on symptoms. The meta-analysis showed that oral antiviral therapy decreases the duration and the associated pain of an outbreak by merely one day." (4). There are also the natural supplements Gene-Eden-VIR and Novirin, which have a formula that was designed to help the immune system target the herpes virus when it is in a latent form.
"We recommend having any sores checked immediately by a doctor. Further, before a woman becomes pregnant, or after she delivers the baby, we recommend taking Gene-Eden-VIR or Novirin to help the immune system target the latent herpes virus." – Greg Bennett, CBCD
All orders of these products are completely confidential, and no information is shared or sold to any third party. Privacy is assured.
Reference:
(1) Field SS "Fatal Neonatal Herpes Simplex Infection Likely from Unrecognized Breast Lesions." J Hum Lact. 2015 Jul 16.
(2) Mammary herpes: a little known mode of neonatal herpes contamination. Published in September 2013. http://www.ncbi.nlm.nih.gov/pubmed/23986091
(3) Dermatoses of the breast in lactation. Published in August 2013. http://www.ncbi.nlm.nih.gov/pubmed/23914890
(4) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published on August 12, 2013. http://gene-eden-kill-virus.com/PP_Gene-Eden-VIR-is-Antiviral.pdf
Media Relations Contact
Mike Davis
585-250-9999
http://www.cbcd.net
View this press release online at: http://rwire.com/623894